109 related articles for article (PubMed ID: 25546404)
21. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
[TBL] [Abstract][Full Text] [Related]
22. Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age.
Lee Y; Scheck AC; Cloughesy TF; Lai A; Dong J; Farooqi HK; Liau LM; Horvath S; Mischel PS; Nelson SF
BMC Med Genomics; 2008 Oct; 1():52. PubMed ID: 18940004
[TBL] [Abstract][Full Text] [Related]
23. Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma.
Di Stefano AL; Fucci A; Frattini V; Labussiere M; Mokhtari K; Zoppoli P; Marie Y; Bruno A; Boisselier B; Giry M; Savatovsky J; Touat M; Belaid H; Kamoun A; Idbaih A; Houillier C; Luo FR; Soria JC; Tabernero J; Eoli M; Paterra R; Yip S; Petrecca K; Chan JA; Finocchiaro G; Lasorella A; Sanson M; Iavarone A
Clin Cancer Res; 2015 Jul; 21(14):3307-17. PubMed ID: 25609060
[TBL] [Abstract][Full Text] [Related]
24. EZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1-dependent manner.
Kim SH; Joshi K; Ezhilarasan R; Myers TR; Siu J; Gu C; Nakano-Okuno M; Taylor D; Minata M; Sulman EP; Lee J; Bhat KP; Salcini AE; Nakano I
Stem Cell Reports; 2015 Feb; 4(2):226-38. PubMed ID: 25601206
[TBL] [Abstract][Full Text] [Related]
25. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution.
Kim H; Zheng S; Amini SS; Virk SM; Mikkelsen T; Brat DJ; Grimsby J; Sougnez C; Muller F; Hu J; Sloan AE; Cohen ML; Van Meir EG; Scarpace L; Laird PW; Weinstein JN; Lander ES; Gabriel S; Getz G; Meyerson M; Chin L; Barnholtz-Sloan JS; Verhaak RG
Genome Res; 2015 Mar; 25(3):316-27. PubMed ID: 25650244
[TBL] [Abstract][Full Text] [Related]
26. Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity.
Meyer M; Reimand J; Lan X; Head R; Zhu X; Kushida M; Bayani J; Pressey JC; Lionel AC; Clarke ID; Cusimano M; Squire JA; Scherer SW; Bernstein M; Woodin MA; Bader GD; Dirks PB
Proc Natl Acad Sci U S A; 2015 Jan; 112(3):851-6. PubMed ID: 25561528
[TBL] [Abstract][Full Text] [Related]
27. Role of micro-RNA (miRNA) in pathogenesis of glioblastoma.
Luo JW; Wang X; Yang Y; Mao Q
Eur Rev Med Pharmacol Sci; 2015; 19(9):1630-9. PubMed ID: 26004603
[TBL] [Abstract][Full Text] [Related]
28. Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution.
Li R; Li H; Yan W; Yang P; Bao Z; Zhang C; Jiang T; You Y
Oncotarget; 2015 Mar; 6(9):7318-24. PubMed ID: 25821160
[TBL] [Abstract][Full Text] [Related]
29. A practical review of prognostic correlations of molecular biomarkers in glioblastoma.
Karsy M; Neil JA; Guan J; Mahan MA; Colman H; Jensen RL
Neurosurg Focus; 2015 Mar; 38(3):E4. PubMed ID: 25727226
[TBL] [Abstract][Full Text] [Related]
30. Advances and challenges in the molecular biology and treatment of glioblastoma-is there any hope for the future?
Veliz I; Loo Y; Castillo O; Karachaliou N; Nigro O; Rosell R
Ann Transl Med; 2015 Jan; 3(1):7. PubMed ID: 25705639
[TBL] [Abstract][Full Text] [Related]
31. Bevacizumab in combination with radiotherapy and temozolomide for patients with newly diagnosed glioblastoma multiforme.
van Linde ME; Verhoeff JJ; Richel DJ; van Furth WR; Reijneveld JC; Verheul HM; Stalpers LJ
Oncologist; 2015 Feb; 20(2):107-8. PubMed ID: 25582142
[TBL] [Abstract][Full Text] [Related]
32. The Bcl-2 inhibitor Obatoclax overcomes resistance to histone deacetylase inhibitors SAHA and LBH589 as radiosensitizers in patient-derived glioblastoma stem-like cells.
Berghauser Pont LM; Spoor JK; Venkatesan S; Swagemakers S; Kloezeman JJ; Dirven CM; van der Spek PJ; Lamfers ML; Leenstra S
Genes Cancer; 2014 Nov; 5(11-12):445-59. PubMed ID: 25568669
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic Utility of Immunohistochemical Detection of MEOX2, SOX11, INSM1 and EGFR in Gliomas.
Soukup J; Gerykova L; Rachelkar A; Hornychova H; Bartos MC; Krupa P; Vitovcova B; Pleskacova Z; Kasparova P; Dvorakova K; Skarkova V; Petera J
Diagnostics (Basel); 2023 Jul; 13(15):. PubMed ID: 37568909
[TBL] [Abstract][Full Text] [Related]
34. Exploring Novel Therapeutic Opportunities for Glioblastoma Using Patient-Derived Cell Cultures.
Ciechomska IA; Wojnicki K; Wojtas B; Szadkowska P; Poleszak K; Kaza B; Jaskula K; Dawidczyk W; Czepko R; Banach M; Czapski B; Nauman P; Kotulska K; Grajkowska W; Roszkowski M; Czernicki T; Marchel A; Kaminska B
Cancers (Basel); 2023 Mar; 15(5):. PubMed ID: 36900355
[TBL] [Abstract][Full Text] [Related]
35. A 3-miRNA Signature Enables Risk Stratification in Glioblastoma Multiforme Patients with Different Clinical Outcomes.
Bafiti V; Ouzounis S; Chalikiopoulou C; Grigorakou E; Grypari IM; Gregoriou G; Theofanopoulos A; Panagiotopoulos V; Prodromidi E; Cavouras D; Zolota V; Kardamakis D; Katsila T
Curr Oncol; 2022 Jun; 29(6):4315-4331. PubMed ID: 35735454
[TBL] [Abstract][Full Text] [Related]
36. Tumor Heterogeneity in Glioblastomas: From Light Microscopy to Molecular Pathology.
Becker AP; Sells BE; Haque SJ; Chakravarti A
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33673104
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemically Characterized Intratumoral Heterogeneity Is a Prognostic Marker in Human Glioblastoma.
Liesche-Starnecker F; Mayer K; Kofler F; Baur S; Schmidt-Graf F; Kempter J; Prokop G; Pfarr N; Wei W; Gempt J; Combs SE; Zimmer C; Meyer B; Wiestler B; Schlegel J
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066251
[TBL] [Abstract][Full Text] [Related]
38. Autophagy inhibition is the next step in the treatment of glioblastoma patients following the Stupp era.
Zhang X; Deibert CP; Kim WJ; Jaman E; Rao AV; Lotze MT; Amankulor NM
Cancer Gene Ther; 2021 Sep; 28(9):971-983. PubMed ID: 32759988
[TBL] [Abstract][Full Text] [Related]
39. Preparation and characterisation of silica-based nanoparticles for cisplatin release on cancer brain cells.
Ortiz-Islas E; Manríquez-Ramírez ME; Sosa-Muñoz A; Almaguer P; Arias C; Guevara P; Hernández-Cortez G; Aguirre-Cruz ML
IET Nanobiotechnol; 2020 May; 14(3):191-197. PubMed ID: 32338626
[TBL] [Abstract][Full Text] [Related]
40. ER stress and UPR activation in glioblastoma: identification of a noncanonical PERK mechanism regulating GBM stem cells through SOX2 modulation.
Peñaranda-Fajardo NM; Meijer C; Liang Y; Dijkstra BM; Aguirre-Gamboa R; den Dunnen WFA; Kruyt FAE
Cell Death Dis; 2019 Sep; 10(10):690. PubMed ID: 31534165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
